Barrington raised the firm's price target on Cimpress to $113 from $95 and keeps an Outperform rating on the shares. Even after the stock price has appreciated 38% year-to-date, the firm sees continued upside potential for Cimpress shares, driven by positive estimate revisions and a modest increase in its valuation multiple assumption, the analyst tells investors.
